• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » WCG Announces IRB Consolidation and New Review Submission Platform

WCG Announces IRB Consolidation and New Review Submission Platform

October 19, 2020

WCG Clinical last week announced it has unified its five separate IRBs under a single WCG IRB banner and launched a new IRB submission platform.

The five IRBs — formerly known as Western IRB (WIRB), Copernicus Group IRB, Midlands IRB, New England IRB and Aspire IRB — will now work as a single entity using the same processes and principles. 

“This is just one further example of our commitment to positively transform the clinical trial process while keeping patient safety as our highest priority,” said Donald A. Deieso, WCG Clinical’s CEO. 

The new Connexus platform, WCG IRB says, provides easier and more secure document submission for clients and allows them to track the status of their review through a process that is fully transparent. Through Connexus, WCG’s goal is “to improve the submission process, eliminate and reduce errors, and thereby achieve the highest ethical standards in the board review process,” says David Forster, WCG Clinical’s chief compliance officer. 

WCG's flagship IRB is celebrating its 52nd anniversary this year. Two more IRBs that WCG acquired were established in the 1980s, Midlands IRB in 1981 and New England IRB in 1989. Copernicus Group followed in 1996 and Aspire IRB in 2004. Together, the five IRBs represent more than 160 years of experience in ethical review and more than 200 review board members.

The newly unified WCG IRB will serve more than 3,100 institutions, including 150 academic medical centers.

Information on using Connexus is available at: https://bit.ly/345GGcR.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing